SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-000619
Filing Date
2021-01-08
Accepted
2021-01-08 08:15:38
Documents
3
Period of Report
2021-01-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K glto-8k_20210108.htm 8-K 44386
2 EX-99.1 glto-ex991_47.htm EX-99.1 13099
3 GRAPHIC gwxkofurkafy000001.jpg GRAPHIC 3829
  Complete submission text file 0001564590-21-000619.txt   64252
Mailing Address GALECTO BIOTECH AB OLE MAALOES VEJ3 COPENHAGEN G7 DK-2200
Business Address GALECTO BIOTECH AB OLE MAALOES VEJ3 COPENHAGEN G7 DK-2200 45-70-70-52-10
Galecto, Inc. (Filer) CIK: 0001800315 (see all company filings)

IRS No.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39655 | Film No.: 21515699
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences